DALLAS – Discussion of the recently released – and significantly expanded – guidelines for treating cholesterol at the American Heart Association annual meeting suggest that the lower costs associated with statin therapy helped pave the way for aggressive treatment recommendations.
With a heavy emphasis on statins, the new LDL-cholesterol guidelines show that gold-standard proof of reduced risk for major cardiovascular...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?